U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C12H15N
Molecular Weight 173.2542
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BICIFADINE

SMILES

[H][C@]12C[C@]1(CNC2)C3=CC=C(C)C=C3

InChI

InChIKey=OFYVIGTWSQPCLF-NEPJUHHUSA-N
InChI=1S/C12H15N/c1-9-2-4-10(5-3-9)12-6-11(12)7-13-8-12/h2-5,11,13H,6-8H2,1H3/t11-,12+/m1/s1

HIDE SMILES / InChI

Molecular Formula C12H15N
Molecular Weight 173.2542
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 16:50:41 UTC 2023
Edited
by admin
on Sat Dec 16 16:50:41 UTC 2023
Record UNII
B0SV3N7J3H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BICIFADINE
INN  
INN  
Official Name English
(±)-1-P-TOLYL-3-AZABICYCLO(3.1.0)HEXANE
Common Name English
3-AZABICYCLO(3.1.0)HEXANE, 1-(4-METHYLPHENYL)-, (±)-
Systematic Name English
bicifadine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C241
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
Code System Code Type Description
INN
4814
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
EPA CompTox
DTXSID20867995
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
ChEMBL
CHEMBL511099
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
FDA UNII
B0SV3N7J3H
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
PUBCHEM
24768032
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
MESH
C034438
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
NCI_THESAURUS
C79930
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
SMS_ID
100000085898
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
EVMPD
SUB05818MIG
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
DRUG BANK
DB04889
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
CAS
71195-57-8
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
WIKIPEDIA
BICIFADINE
Created by admin on Sat Dec 16 16:50:43 UTC 2023 , Edited by admin on Sat Dec 16 16:50:43 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
METABOLIC ENZYME -> SUBSTRATE
EXCRETED UNCHANGED
FECAL; URINE
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
Related Record Type Details
METABOLITE -> PARENT
URINE
METABOLITE -> PARENT
MAJOR
PLASMA
METABOLITE -> PARENT
MAJOR
PLASMA
METABOLITE -> PARENT
Combined with acid metabolite accounted for another 22.4% of the dose
URINE
METABOLITE -> PARENT
MAJOR
URINE
METABOLITE -> PARENT
FECAL
METABOLITE -> PARENT
URINE
METABOLITE -> PARENT
Neither unchanged bicifadine nor M12 were detected in urine or feces
MAJOR
PLASMA
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC ORAL ADMINISTRATION

SINGLE DOSE

Tmax PHARMACOKINETIC SINGLE DOSE

ORAL ADMINISTRATION